Logo

American Heart Association

  106
  0


Final ID: Su2022

Single Ventricle Palliation Pathways: Patient Characteristics and Outcomes

Abstract Body (Do not enter title and authors here): Introduction
The choice between conventional surgical (SP) and hybrid (HP) stage 1 palliation for single ventricle heart disease remains debated. Pulmonary artery banding and prostaglandins followed by delayed surgical stage 1 (DSP) remains another option. HP is proposed for high-risk patients. We aimed to describe index hospitalization outcomes for patients undergoing these 3 pathways. We hypothesized that patients undergoing HP and DSP have more comorbid conditions, higher morbidity, and longer length of stay (LOS).

Methods
Using the Pediatric Health Information System data, January 2016 – August 2023, we analyzed the characteristics and index hospitalization outcomes for patients with single ventricle disease undergoing SP, HP, and DSP.

Results
Our final cohort included 1,872 patients (1,573 SP; 176 HP; 123 DSP). Prematurity was most common (45.5%) in the DSP compared to the HP (27.8%) and SP (9.5%) groups (P<0.001); the rate of small for gestational age birth (SGA, <2.5 kg) was similarly distributed. Non-cardiac comorbidities were most prevalent in DSP (neurologic, gastrointestinal, need home technology) and HP (respiratory). LOS (days) was highest for DSP (median 130, IQR:69–195) compared to HP (median 61, IQR:37–139) and SP (median 45, IQR:29–80)(P<0.001). Disposition varied (P<0.001), with in-hospital mortality highest among HP (25.6%) compared to DSP (13.8%) and SP (11.3%); the rate of index hospitalization heart transplant was 8.5% for HP, DSP 0.8%, and SP 0.9%.

Among patients born prematurely or SGA, LOS was longest for DSP (median 143, IQR:88–216) followed by HP (median 72, IQR:52–139) and SP (median 59, IQR:36–124)(P<0.001). Disposition also varied (P=0.004), with higher in-hospital mortality among HP (35.9%) compared to DSP (16.9%) and SP (19.9%); transplant was highest among HP (4.7%) compared to DSP (0%) and SP (0.8%).

Adjusted total costs per hospital day did not vary significantly.

Conclusions
Patients undergoing DSP and HP are more often premature or SGA. Patients undergoing HP are most likely to have index hospitalization mortality or transplant. While recognizing the limitations of administrative databases, our data does describe the current utilization trend and outcomes for SP, HP, and DSP.
  • Kuntz, Michael  ( Monroe Carell Jr. Children's Hospital at Vanderbilt , Nashville , Tennessee , United States )
  • Staffa, Steven  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Valencia, Eleonore  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Nasr, Viviane  ( Boston Children's Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Michael Kuntz: DO NOT have relevant financial relationships | Steven Staffa: DO NOT have relevant financial relationships | Eleonore Valencia: DO NOT have relevant financial relationships | Viviane Nasr: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Pediatric Cardiac Surgery

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts on this topic:
Cellular Crosstalk in Endocardial Fibroelastosis: NRG Signaling Dysregulation Contributes to Fibrosis and Myocardial Dysfunction in Hypoplastic Left Heart Complex

Diaz-gil Daniel, Seidman Christine, Friehs Ingeborg, Morton Sarah, Brown Kemar, Wei Eric, Saraci Kerstin, Von Piechowski Magnus, Emani Sitaram, Del Nido Pedro, Seidman Jonathan

Advanced Complementary Imaging Analysis of Single Ventricle Patients Using Cardiac Magnetic Resonance and Echocardiography

Naum Athanasios, Loke Yue-hin, Meyers Brett, Payne Ronald, Vlachos Pavlos

More abstracts from these authors:
Comparison of One-Year Survival between Norwood and Hybrid Pathways for Hypoplastic Left Heart Syndrome Infants- A Multicenter Registry Data Analysis

Zurakowski David, Staffa Steven, Hill Garick, Mccoy Allison, Sinha Pranava

CMR can discriminate need for biopsy and rejection therapy in children post heart transplant

Vegulla Ravi, Staffa Steven, Zurakowski David, Cross Russell, Olivieri Laura, Ceneri Nicolle, Richmann Devika, Mouzakis Nicholas, Hamman Karin, Kanter Joshua, Berger John, Downing Tacy, Loke Yue-hin

You have to be authorized to contact abstract author. Please, Login
Not Available